Muscle atrophy inhibitor and method for inhibiting muscle atrophy

JP2026095737APending Publication Date: 2026-06-11YAMASA SHOYU CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
YAMASA SHOYU CO LTD
Filing Date
2026-04-07
Publication Date
2026-06-11

AI Technical Summary

Benefits of technology

【0021】 本願発明の、ピリミジンヌクレオチド又はその前駆体を有効成分として含有する筋萎縮抑制剤は、筋萎縮に起因する有病者及び高齢者のQOL改善に資する新たな手段を提供することにつながる。また、本願発明の筋萎縮抑制剤を筋萎縮が発症する前に使用することで、その予防も可能である。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026095737000001
    Figure 2026095737000001
  • Figure 2026095737000002
    Figure 2026095737000002
  • Figure 2026095737000003
    Figure 2026095737000003
Patent Text Reader

Abstract

To provide a muscle atrophy inhibitor that contributes to improving the quality of life (QOL) of patients with diseases caused by muscle atrophy and elderly individuals. [Solution] A muscle atrophy inhibitor containing pyrimidine nucleotide or its precursor as an active ingredient.
Need to check novelty before this filing date? Find Prior Art

Claims

[Claim 1] A muscle atrophy inhibitor and a method for inhibiting muscle atrophy as described in the specification.